What are the ethical considerations related to the allocation of limited resources for the treatment of infections caused by highly resistant bacteria like Pseudomonas aeruginosa?

May 14, 2014 ... A Pseudomonas aeruginosa type VI secretion phospholipase D effector targets both prokaryotic and eukaryotic cells. Cell Host Microbe. 2014 May ... Pseudomonas Aeruginosa Infection. A Pseudomonas aeruginosa infection is a condition that can affect your skin, blood, lungs, GI tract and other parts of your ... Multidrug efflux pumps are among the main Pseudomonas aeruginosa antibiotic-resistance determinants. Besides, efflux pumps are also involved in other ... Pseudomonas bacteria, including Pseudomonas aeruginosa, are present throughout the world in soil and water. These bacteria favor moist areas, such as sinks ... Oct 12, 2022 ... PAO1 and PA14 are common laboratory reference strains, modeling moderately and hyper-virulent phenotypes, respectively. Jul 5, 2024 ... A series of epidemic clones emerged and expanded between 1850 and 2000, indicating recent selective pressures, possibly driven by industrialization, associated ... Pseudomonas aeruginosa: Symptoms, Causes, Videos & Quizzes | Learn Fast for Better Retention! Jul 12, 2018 ... P. aeruginosa is an opportunistic pathogen and it rarely affects healthy individuals. It can cause a wide range of infections, particularly in ... Pseudomonas aeruginosa infections are the predominant driver of CF lung disease, and airway isolates are frequently resistant to multiple antimicrobials ... Culti-Loops™ Pseudomonas aeruginosa ATCC™ 27853™ ... Have Questions? ... Have questions about this product? Ask our AI assisted search. This is an AI-powered search ...